Viewing Study NCT03366766

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:17 PM
Ignite Modification Date: 2026-02-21 @ 9:49 AM
Study NCT ID: NCT03366766
Status: COMPLETED
Last Update Posted: 2023-04-03
First Post: 2017-12-04
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Nivolumab, Cisplatin, and Pemetrexed Disodium or Gemcitabine Hydrochloride in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery
Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Squamous Non-Small Cell Lung Carcinoma View
None Stage I Non-Small Cell Lung Cancer View
None Stage IA Non-Small Cell Lung Carcinoma View
None Stage IB Non-Small Cell Lung Carcinoma View
None Stage II Non-Small Cell Lung Cancer View
None Stage IIA Non-Small Cell Lung Carcinoma View
None Stage IIB Non-Small Cell Lung Carcinoma View
None Stage IIIA Non-Small Cell Lung Cancer View
Keywords: